Anxiety and depression in patients with alpha-1 antitrypsin deficiency: current insights and impact on quality of life
Tatsiana Beiko, Charlie StrangeDivision of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC, USAAbstract: Chronic physical illness is associated with significant vulnerability for emotional disorders. Some studies suggest anxiety and depression are common co...
Main Authors: | Beiko T, Strange C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/anxiety-and-depression-in-patients-with-alpha-1-antitrypsin-deficiency-peer-reviewed-article-TCRM |
Similar Items
-
Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01) -
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
by: Rahaghi FF, et al.
Published: (2020-12-01) -
The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01) -
The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01) -
Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)